Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management. (Q35889876)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372473%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

review article

1 reference

title

Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372473%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

Daniel Couriel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372473%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Humberto Caldera

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372473%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

language of work or name

English

0 references

publication date

1 November 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372473%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372473%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372473%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372473%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

1936-1946

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372473%20AND%20SRC:MED&resulttype=core&format=json

Accumulation and activation-induced release of preformed Fas (CD95) ligand during the pathogenesis of experimental graft-versus-host disease

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

Bone marrow transplantation from unrelated donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Acute graft-vs-host disease: pathobiology and management

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

New therapeutic modalities in the treatment of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

The Pathophysiology of Acute Graft-versus-Host Disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Reciprocal control of T helper cell and dendritic cell differentiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Plasmacytoid dendritic cells: do they have a role in immune responses after hematopoietic cell transplantation?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Role of plasmacytoid dendritic cells in immunity and tolerance after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Critical role of interleukin-2 in the development of acute graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

A phase I-II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Prognostic value of apoptotic cells and infiltrating neutrophils in graft-versus-host disease of the gastrointestinal tract in humans: TNF and Fas expression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Serum levels of cytokines correlate to donor chimerism and acute graft-vs.-host disease after haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Role of tumor necrosis factor-alpha in graft-versus-host disease and graft-versus-leukemia responses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Clinical "cytokine storm" as revealed by monocyte intracellular flow cytometry: correlation of tumor necrosis factor alpha with severe gut graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Viral immune evasion due to persistence of activated T cells without effector function

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected].

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Marrow transplantation from related donors other than HLA-identical siblings

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Depletion of host reactive T cells by photodynamic cell purging and prevention of graft versus host disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

The proapoptotic factor Nix is coexpressed with Bcl-xL during terminal erythroid differentiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Diagnosis of gastrointestinal graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Acute bleeding after allogeneic bone marrow transplantation: association with graft versus host disease and effect on survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

A systematic approach to hepatic complications in hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Lack of specificity in skin biopsy specimens to assess for acute graft-versus-host disease in initial 3 weeks after bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

New developments in allotransplant immunology.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Novel pharmacotherapeutic approaches to prevention and treatment of GVHD.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Tacrolimus: a new agent for the prevention of graft-versus-host disease in hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Tacrolimus for prevention of graft-versus-host disease after mismatched unrelated donor cord blood transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Practical considerations in the use of tacrolimus for allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

How should corticosteroids be used in the treatment of acute GVHD? EBMT Chronic Leukemia Working Party. European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Prednisone therapy for acute graft-versus-host disease: short- versus long-term treatment. A prospective randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Advances in the treatment of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

A humanized antibody that binds to the interleukin 2 receptor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

New indications for treatment of chronic inflammation by TNF-alpha blockade

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Non-Fc receptor-binding humanized anti-CD3 antibodies induce apoptosis of activated human T cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

P-glycoprotein targeting: a unique strategy to selectively eliminate immunoreactive T cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Optimized clinical-scale culture conditions for ex vivo selective depletion of host-reactive donor lymphocytes: a strategy for GvHD prophylaxis in allogeneic PBSC transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Definitive separation of graft-versus-leukemia- and graft-versus-host-specific CD4+ T cells by virtue of their receptor beta loci sequences

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Transplantation of anergic histoincompatible bone marrow allografts

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Specific depletion of alloreactive T cells in HLA-identical siblings: a method for separating graft-versus-host and graft-versus-leukaemia reactions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Dendritic cell-activated CD44hiCD8+ T cells are defective in mediating acute graft-versus-host disease but retain graft-versus-leukemia activity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021

Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20613

7 January 2021